A new report finds 11 states and the District of Columbia don’t have enough doctors who are able to prescribe a treatment experts say is key to treating opioid addiction.
The consulting firm Avalere Health, which counts pharmaceutical and life science companies among its clients, found that 11 states and the District of Columbia lack enough providers certified to prescribe buprenorphine, which helps prevent relapses among addicts. The findings highlight the importance of expanding the number of healthcare providers who can prescribe the treatment, Avalere said.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.